These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 29235601)
1. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines. Mandal P; Kundu BK; Vyas K; Sabu V; Helen A; Dhankhar SS; Nagaraja CM; Bhattacherjee D; Bhabak KP; Mukhopadhyay S Dalton Trans; 2018 Jan; 47(2):517-527. PubMed ID: 29235601 [TBL] [Abstract][Full Text] [Related]
2. Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various cancer cell lines. Tabrizi L; Olasunkanmi LO; Fadare OA Dalton Trans; 2019 Jan; 48(2):728-740. PubMed ID: 30560261 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity. Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741 [TBL] [Abstract][Full Text] [Related]
4. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies. Bhattacharyya S; Purkait K; Mukherjee A Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907 [TBL] [Abstract][Full Text] [Related]